Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

475 POSTS 0 COMMENTS

The Critical Role of Patents in Novel Drug Development

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...

Psychedelics Versus Cannabis: Exploring their Impact on Treating Mental Illness

Progressive Law Firm Zuber Lawler Is at Forefront of Modern Psychedelic...

SALT Talks: Psychedelics with Sa’ad Shah (Noetic Fund) & JR Rahn...

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results...

Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider...

NeonMind Submits Applications to Health Canada for Product Formulas to Support...

Nova Mentis Psilocybin Approved for Shipment to Italy

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading...

1...444546...48 Page 45 of 48

EDITOR PICKS

Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona...

Field Notes #1: Psychiatrists, Regulators, Ibogaine, and the Race for Psilocybin...

At the Federal Psychedelic Medicine Summit, the Mood Was Urgent, Practical,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime